Form 8-K - Current report:
SEC Accession No. 0001437749-23-012324
Filing Date
2023-05-03
Accepted
2023-05-03 16:06:50
Documents
15
Period of Report
2023-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20230425_8k.htm   iXBRL 8-K 30031
2 EXHIBIT 99.1 ex_506613.htm EX-99.1 66327
7 ex_506613img001.jpg GRAPHIC 3748
  Complete submission text file 0001437749-23-012324.txt   243519

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA opk-20230503.xsd EX-101.SCH 3592
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20230503_def.xml EX-101.DEF 11528
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20230503_lab.xml EX-101.LAB 15413
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20230503_pre.xml EX-101.PRE 11684
9 EXTRACTED XBRL INSTANCE DOCUMENT opk20230425_8k_htm.xml XML 2568
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 23883701
SIC: 2834 Pharmaceutical Preparations